#USA #Houston #Sino Biological #SwiftFluo #TR-FRET Kits

Introduction

Sino Biological, Inc., a prominent player in the biotechnology sector, has recently introduced an innovative product that is set to change the landscape of kinase inhibitor screening. The SwiftFluo® TR-FRET Kinase Assay Kits are designed for high-throughput applications, providing researchers with a ready-to-use solution that significantly enhances the efficiency of kinase activity detection and screening processes.

Advanced Technology

These kits utilize Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET), a cutting-edge technology known for its exceptional sensitivity and low background noise. This allows for reliable and reproducible results that surpass traditional screening methods, including radioactive assays and ELISA techniques. As researchers strive for quicker and more efficient ways to screen potential drug candidates, the SwiftFluo® kits deliver a scalable solution that meets these demands.

Comprehensive Coverage

One of the standout features of the SwiftFluo® TR-FRET kits is their impressive range of targets. The kits are optimized for profiling over 60 tyrosine kinases, 150 serine/threonine kinases, and 15 cyclin-dependent kinases. This broad coverage across key signaling pathways makes these kits invaluable for researchers focused on cancer research, drug discovery, and various other therapeutic areas.

Enhanced User Experience

According to Dr. Rob Burgess, Chief Business Officer at Sino Biological US, the SwiftFluo® TR-FRET kits are designed with user convenience in mind. Researchers can perform homogeneous, no-wash assays in a simple add-and-read format. This compatibility with standard high-throughput screening platforms eliminates the complexities associated with conventional assay development, thus significantly reducing the time required to set up and execute experiments.

Flexibility and Customization

In addition to the assay kits, Sino Biological provides a variety of related substrates and individual biologically active kinases. This availability allows researchers to tailor their assay designs according to specific research needs—a flexibility that is crucial in today’s fast-paced scientific environment.

Commitment to Quality

Sino Biological’s dedication to quality is evident in its commitment to offering high-performance products that are both cost-efficient and reliable. Dr. Jie Zhang, General Manager of Sino Biological, highlighted that the SwiftFluo® TR-FRET kits were meticulously developed to balance ease of use with the rigorous demands of high-throughput screening campaigns. Reliable data generation is critical for researchers, and these kits are expected to play a pivotal role in advancing kinase-related drug discovery.

Exploring the New Kits

Researchers interested in these groundbreaking assay kits can visit Sino Biological's website for more information or download the technical QA handbook that details how the SwiftFluo® TR-FRET kits can enhance kinase drug discovery efforts.

About Sino Biological

Founded in 2007, Sino Biological has established itself as a leader in biotechnology, delivering high-quality recombinant proteins, antibodies, and CRO services to researchers across more than 90 countries. The company’s extensive product portfolio supports various areas of scientific research, including drug discovery, vaccine development, and diagnostics.

Conclusion

With the launch of the SwiftFluo® TR-FRET kits, Sino Biological is not just introducing a new product, but is pioneering a transformative approach to kinase inhibitor screening. By focusing on accuracy, efficiency, and user accessibility, these kits are likely to become an essential tool in the arsenal of researchers worldwide, pushing the boundaries of drug discovery and development.